Keiji Sugimoto
- Molecular Biology top 5%
- Genetics top 5%
- Ecology top 5%
- Oncology top 10%
- Hematology top 5%
- Co-authors
- M. TakanamiHiroyuki SugisakiToshio OkamotoTuneko OkazakiR OkazakiK. SakabeAkio SuginoHiroshi Kimurâ
- Topics
- Lymphoma Diagnosis and Treatment (24 papers)Chronic Myeloid Leukemia Treatments (15 papers)Chronic Lymphocytic Leukemia Research (13 papers)
- Cited by
- GeneticsMolecular BiologyEcology
- Partner nations
- JapanUnited KingdomUnited States
In The Last Decade
Keiji Sugimoto
97 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 108
- Molecular Biology 1.4k
- Genetics 595
- Ecology 445
- Oncology 296
- Hematology 190
Countries citing papers authored by Keiji Sugimoto
This map shows the geographic impact of Keiji Sugimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiji Sugimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiji Sugimoto more than expected).
Fields of papers citing papers by Keiji Sugimoto
This network shows the impact of papers produced by Keiji Sugimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiji Sugimoto. The network helps show where Keiji Sugimoto may publish in the future.
Co-authorship network of co-authors of Keiji Sugimoto
This figure shows the co-authorship network connecting the top 25 collaborators of Keiji Sugimoto. A scholar is included among the top collaborators of Keiji Sugimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiji Sugimoto. Keiji Sugimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 21 | |
| 4 | 9 | |
| 5 | 5 | |
| 6 | 4 | |
| 7 | 2 | |
| 8 | 3 | |
| 9 | 89 | |
| 10 | 7 | |
| 11 | 8 | |
| 12 | 13 | |
| 13 | 26 | |
| 14 | 3 | |
| 15 | 2 | |
| 16 | 7 | |
| 17 | 10 | |
| 18 | 8 | |
| 19 | 2 | |
| 20 | 3 |
About Keiji Sugimoto
Keiji Sugimoto is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 107 papers that have together received 2.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (24 papers), Chronic Myeloid Leukemia Treatments (15 papers) and Chronic Lymphocytic Leukemia Research (13 papers). The work is most often cited by research in Genetics (595 citations), Molecular Biology (1.4k citations) and Ecology (445 citations). Keiji Sugimoto has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include M. Takanami, Hiroyuki Sugisaki, Toshio Okamoto, Tuneko Okazaki, R Okazaki, K. Sakabe, Akio Sugino, Hiroshi Kimurâ, Ayaka Oka and Ewald Beck. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.